- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00413751
Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes
December 19, 2006 updated by: Walter Reed Army Medical Center
The objective of this study is to evaluate the effect of brimonidine tartrate ophthalmic solution 0.15% (Alphagan P) on pupil diameter under different luminance conditions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20307
- Walter Reed Army Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult active duty personnel between 18 and 50 years of age with best corrected visual acuity of 20/20 or better.
Exclusion Criteria:
- Patients not meeting above stated age criteria
- Females that are pregnant or lactating (non pregnant females of childbearing potential will have pregnancy test prior to participating in study)
- History of serious ocular, neurological, cardiovascular disease
- History of severe systemic disease
- History of arrhythmias or high blood pressure
- Patients currently taking any type of ocular or systemic medications except multivitamins.
- Patients with abnormal pupil shape, Addie's pupil, anisocoria, or abnormal pupil defect.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Prospective
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: KRAIG S. BOWER, MD, Walter Reed Army Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
December 19, 2006
First Submitted That Met QC Criteria
December 19, 2006
First Posted (Estimate)
December 20, 2006
Study Record Updates
Last Update Posted (Estimate)
December 20, 2006
Last Update Submitted That Met QC Criteria
December 19, 2006
Last Verified
December 1, 2006
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- WRAMC WU #03-23004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Brimonidine tartrate ophthalmic solution 0.15% (Alphagan P)
-
CHA UniversityHanlim Pharm. Co., Ltd.UnknownGlaucoma | Ocular HypertensiveKorea, Republic of
-
Uptown Eye SpecialistsUnknownPterygium | Subconjunctival Hemorrhage
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleChina
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | GlaucomaChina
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
Sandeep Jain, MDOcugenTerminatedDry Eye | Meibomian Gland Dysfunction | Ocular Graft vs Host DiseaseUnited States
-
University of TorontoDr. Efrem MandelcornCompletedPost-Injection Intraocular Pressure Spikes
-
Sun Pharma Advanced Research Company LimitedCompletedOcular Hypertension | Open Angle GlaucomaUnited States